<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>mesoridazine</title><link>http://www.unboundmedicine.com/medline/ebm/research/mesoridazine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Identification of Novel Substrates for Human Cytochrome P450 2J2.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923256/full_citation/Identification_of_Novel_Substrates_for_Human_Cytochrome_P450_2J2_</link><description>Lee CA, Neul D, Clouser-Roche A, et al. <br/><span class="title">Identification of Novel Substrates for Human Cytochrome P450 2J2. [JOURNAL ARTICLE]</span><br/><span class="source" title="Drug metabolism and disposition: the biological fate of chemicals">Drug Metab Dispos 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923256/abstract/Identification_of_Novel_Substrates_for_Human_Cytochrome_P450_2J2_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923256/full_citation/Identification_of_Novel_Substrates_for_Human_Cytochrome_P450_2J2_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923256/Identification_of_Novel_Substrates_for_Human_Cytochrome_P450_2J2_">Find Related Articles</a> </description></item><item><title>Relevance of CYP2D6 -1584C&gt;G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19604081/full_citation/Relevance_of_CYP2D6__1584C&gt;G_polymorphism_for_thioridazine:mesoridazine_plasma_concentration_ratio_in_psychiatric_patients_</link><description>Dorado P, Peñas-LLedó EM, de la Rubia A, et al. <br/><span class="title">Relevance of CYP2D6 -1584C&gt;G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Pharmacogenomics">Pharmacogenomics 2009 Jul; 10(7):1083-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19604081/abstract/Relevance_of_CYP2D6__1584C&gt;G_polymorphism_for_thioridazine:mesoridazine_plasma_concentration_ratio_in_psychiatric_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19604081/full_citation/Relevance_of_CYP2D6__1584C&gt;G_polymorphism_for_thioridazine:mesoridazine_plasma_concentration_ratio_in_psychiatric_patients_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19604081/Relevance_of_CYP2D6__1584C&gt;G_polymorphism_for_thioridazine:mesoridazine_plasma_concentration_ratio_in_psychiatric_patients_">Find Related Articles</a> </description></item><item><title>Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19028375/full_citation/Hospitalization_risk_associated_with_typical_and_atypical_antipsychotic_use_in_community_dwelling_elderly_patients_</link><description>Aparasu RR, Jano E, Johnson ML, et al. <br/><span class="title">Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. [Journal Article]</span><br/><span class="source" title="The American journal of geriatric pharmacotherapy">Am J Geriatr Pharmacother 2008 Oct; 6(4):198-204.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19028375/abstract/Hospitalization_risk_associated_with_typical_and_atypical_antipsychotic_use_in_community_dwelling_elderly_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19028375/full_citation/Hospitalization_risk_associated_with_typical_and_atypical_antipsychotic_use_in_community_dwelling_elderly_patients_">Full Citation</a></description></item><item><title>Factors Affecting Drug Concentrations and QT Interval During Thioridazine Therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17460606/full_citation/Factors_Affecting_Drug_Concentrations_and_QT_Interval_During_Thioridazine_Therapy_</link><description>Thanacoody RH, Daly AK, Reilly JG, et al. <br/><span class="title">Factors Affecting Drug Concentrations and QT Interval During Thioridazine Therapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Clin Pharmacol Ther 2007 Apr 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17460606/abstract/Factors_Affecting_Drug_Concentrations_and_QT_Interval_During_Thioridazine_Therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17460606/full_citation/Factors_Affecting_Drug_Concentrations_and_QT_Interval_During_Thioridazine_Therapy_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/6100195 http://dx.doi.org/10.1038/sj.clpt.6100195">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/17460606/Factors_Affecting_Drug_Concentrations_and_QT_Interval_During_Thioridazine_Therapy_">Find Related Articles</a> </description></item><item><title>Comparison of the Effects of Thioridazine and Mesoridazine on the QT Interval in Healthy Adults After Single Oral Doses.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17410120/full_citation/Comparison_of_the_Effects_of_Thioridazine_and_Mesoridazine_on_the_QT_Interval_in_Healthy_Adults_After_Single_Oral_Doses_</link><description>Salih IS, Thanacoody RH, McKay GA, et al. <br/><span class="title">Comparison of the Effects of Thioridazine and Mesoridazine on the QT Interval in Healthy Adults After Single Oral Doses. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Clin Pharmacol Ther 2007 Apr 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17410120/abstract/Comparison_of_the_Effects_of_Thioridazine_and_Mesoridazine_on_the_QT_Interval_in_Healthy_Adults_After_Single_Oral_Doses_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17410120/full_citation/Comparison_of_the_Effects_of_Thioridazine_and_Mesoridazine_on_the_QT_Interval_in_Healthy_Adults_After_Single_Oral_Doses_">Full Citation</a> | <a href="http://dx.doi.org/10.1038/sj.clpt.6100194 http://linkinghub.elsevier.com/retrieve/pii/6100194">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/17410120/Comparison_of_the_Effects_of_Thioridazine_and_Mesoridazine_on_the_QT_Interval_in_Healthy_Adults_After_Single_Oral_Doses_">Find Related Articles</a> </description></item><item><title>No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17345072/full_citation/No_effect_of_the_CYP1A2_1F_genotype_on_thioridazine_mesoridazine_sulforidazine_plasma_concentrations_in_psychiatric_patients_</link><description>Dorado P, Berecz R, Peñas-Lledó EM, et al. <br/><span class="title">No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Eur J Clin Pharmacol 2007 Mar 8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17345072/full_citation/No_effect_of_the_CYP1A2_1F_genotype_on_thioridazine_mesoridazine_sulforidazine_plasma_concentrations_in_psychiatric_patients_">Full Citation</a> | <a href="http://dx.doi.org/10.1007/s00228-007-0284-6">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/17345072/No_effect_of_the_CYP1A2_1F_genotype_on_thioridazine_mesoridazine_sulforidazine_plasma_concentrations_in_psychiatric_patients_">Find Related Articles</a> </description></item><item><title>ALTERING EXTRACELLULAR POTASSIUM CONCENTRATION DOES NOT MODULATE DRUG BLOCK OF HUMAN ETHER-A-GO-GO-RELATED GENE (hERG) CHANNELS.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17042915/full_citation/ALTERING_EXTRACELLULAR_POTASSIUM_CONCENTRATION_DOES_NOT_MODULATE_DRUG_BLOCK_OF_HUMAN_ETHER_A_GO_GO_RELATED_GENE__hERG__CHANNELS_</link><description>Limberis JT, Su Z, Cox BF, et al. <br/><span class="title">ALTERING EXTRACELLULAR POTASSIUM CONCENTRATION DOES NOT MODULATE DRUG BLOCK OF HUMAN ETHER-A-GO-GO-RELATED GENE (hERG) CHANNELS. [Journal Article]</span><br/><span class="source" title="Clinical and experimental pharmacology &amp; physiology.">Clin Exp Pharmacol Physiol 2006 Nov; 33(11):1059-65.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17042915/abstract/ALTERING_EXTRACELLULAR_POTASSIUM_CONCENTRATION_DOES_NOT_MODULATE_DRUG_BLOCK_OF_HUMAN_ETHER_A_GO_GO_RELATED_GENE__hERG__CHANNELS_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17042915/full_citation/ALTERING_EXTRACELLULAR_POTASSIUM_CONCENTRATION_DOES_NOT_MODULATE_DRUG_BLOCK_OF_HUMAN_ETHER_A_GO_GO_RELATED_GENE__hERG__CHANNELS_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/17042915/ALTERING_EXTRACELLULAR_POTASSIUM_CONCENTRATION_DOES_NOT_MODULATE_DRUG_BLOCK_OF_HUMAN_ETHER_A_GO_GO_RELATED_GENE__hERG__CHANNELS_">Find Related Articles</a> </description></item><item><title>Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17017818/full_citation/Efficacy_of_typical_and_atypical_antipsychotics_for_primary_and_comorbid_anxiety_symptoms_or_disorders:_a_review_</link><description>Gao K, Muzina D, Gajwani P, et al. <br/><span class="title">Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. [Journal Article]</span><br/><span class="source" title="The Journal of clinical psychiatry.">J Clin Psychiatry 2006 Sep; 67(9):1327-40.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17017818/abstract/Efficacy_of_typical_and_atypical_antipsychotics_for_primary_and_comorbid_anxiety_symptoms_or_disorders:_a_review_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17017818/full_citation/Efficacy_of_typical_and_atypical_antipsychotics_for_primary_and_comorbid_anxiety_symptoms_or_disorders:_a_review_">Full Citation</a> | <a href="http://article.psychiatrist.com/%3fContentType=START%26amp;ID=10002742">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/17017818/Efficacy_of_typical_and_atypical_antipsychotics_for_primary_and_comorbid_anxiety_symptoms_or_disorders:_a_review_">Find Related Articles</a> </description></item><item><title>Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16685461/full_citation/Effect_of_thioridazine_on_gap_junction_intercellular_communication_in_connexin_43_expressing_cells_</link><description>Matesic DF, Abifadel DN, Garcia EL, et al. <br/><span class="title">Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Cell Biol Toxicol 2006 May 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16685461/abstract/Effect_of_thioridazine_on_gap_junction_intercellular_communication_in_connexin_43_expressing_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16685461/full_citation/Effect_of_thioridazine_on_gap_junction_intercellular_communication_in_connexin_43_expressing_cells_">Full Citation</a> | <a href="http://dx.doi.org/10.1007/s10565-006-0047-7">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16685461/Effect_of_thioridazine_on_gap_junction_intercellular_communication_in_connexin_43_expressing_cells_">Find Related Articles</a> </description></item><item><title>Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16272405/full_citation/Characterization_of_human_cytochrome_p450_enzymes_involved_in_the_metabolism_of_the_piperidine_type_phenothiazine_neuroleptic_thioridazine_</link><description>Wójcikowski J, Maurel P, Daniel WA <br/><span class="title">Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine. [Journal Article]</span><br/><span class="source" title="Drug metabolism and disposition:  the biological fate of chemicals.">Drug Metab Dispos 2006 Mar; 34(3):471-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16272405/abstract/Characterization_of_human_cytochrome_p450_enzymes_involved_in_the_metabolism_of_the_piperidine_type_phenothiazine_neuroleptic_thioridazine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16272405/full_citation/Characterization_of_human_cytochrome_p450_enzymes_involved_in_the_metabolism_of_the_piperidine_type_phenothiazine_neuroleptic_thioridazine_">Full Citation</a> | <a href="http://dmd.aspetjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=16272405">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16272405/Characterization_of_human_cytochrome_p450_enzymes_involved_in_the_metabolism_of_the_piperidine_type_phenothiazine_neuroleptic_thioridazine_">Find Related Articles</a> </description></item></channel></rss>